Masimo Corporation $MASI Shares Sold by Nordea Investment Management AB

Nordea Investment Management AB reduced its holdings in shares of Masimo Corporation (NASDAQ:MASI) by 12.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,319 shares of the medical equipment provider’s stock after selling 4,180 shares during the period. Nordea Investment Management AB owned approximately 0.05% of Masimo worth $3,690,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Viking Global Investors LP purchased a new stake in shares of Masimo during the second quarter worth about $129,096,000. Squarepoint Ops LLC boosted its stake in Masimo by 738.8% in the 3rd quarter. Squarepoint Ops LLC now owns 620,932 shares of the medical equipment provider’s stock worth $91,619,000 after purchasing an additional 546,905 shares in the last quarter. Alyeska Investment Group L.P. boosted its stake in Masimo by 21.7% in the 3rd quarter. Alyeska Investment Group L.P. now owns 1,381,085 shares of the medical equipment provider’s stock worth $203,779,000 after purchasing an additional 246,595 shares in the last quarter. Grantham Mayo Van Otterloo & Co. LLC purchased a new stake in Masimo during the 2nd quarter worth approximately $40,468,000. Finally, Westfield Capital Management Co. LP grew its position in Masimo by 20.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,419,250 shares of the medical equipment provider’s stock worth $209,410,000 after purchasing an additional 238,047 shares during the last quarter. 85.96% of the stock is currently owned by hedge funds and other institutional investors.

Masimo Stock Performance

Shares of NASDAQ MASI opened at $177.11 on Friday. The company has a current ratio of 2.49, a quick ratio of 1.47 and a debt-to-equity ratio of 0.72. Masimo Corporation has a 12 month low of $125.94 and a 12 month high of $179.00. The company has a 50 day simple moving average of $159.93 and a two-hundred day simple moving average of $148.32. The stock has a market cap of $9.51 billion, a price-to-earnings ratio of -16.80, a PEG ratio of 1.79 and a beta of 1.21.

Analyst Upgrades and Downgrades

MASI has been the subject of a number of research analyst reports. BTIG Research cut shares of Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. Needham & Company LLC reissued a “hold” rating on shares of Masimo in a report on Monday, December 1st. Raymond James Financial lowered Masimo from an “outperform” rating to a “market perform” rating in a research note on Friday. Wells Fargo & Company raised Masimo to a “hold” rating in a research report on Wednesday, March 18th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Masimo in a research note on Thursday, January 22nd. Eight investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Reduce” and a consensus price target of $181.17.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.